Pharmaceuticals are a critical and often lifesaving tool for managing disease, but we will never solve our chronic disease crisis through a mindset of mere management.
Non–FDA-approved medications may be accessed for patient care via 3 alternative pathways: expanded access, the Right to Try Act, and off-label use, which are reviewed in this article.
Treatment often involves a combination of preventive measures, topical therapies, and systemic treatments.
Brigimadlin is a new oral MDM2-p53 antagonist under investigation as a potential first-line therapy to improve outcomes for patients with advanced or metastatic dedifferentiated liposarcoma.
Patient monitoring significantly improved for patients seen in the pharmacist-led clinic due to greater efforts to order labs per policy and prescribe an appropriate DOAC dose.
The adjuvant therapy has demonstrated varied efficacy for patients.
IMROZ study data show Isa-VRd may be a new standard of care.
Despite Muslim patients’ need for halal medication, more than 80% of pharmacists were found to lack knowledge about where to look to find alternative medications that are halal.
With health systems undergoing a necessary reevaluation of how they allocate their funding into the future, initial data support the need for them to offer a hospital-at-home option for patients they serve.
The use of adulterated cannabinoids mixed with insecticides is becoming more common.
Environmental conditions and air pollution affect health by causing injuries and fatalities, exacerbating respiratory and cardiovascular diseases, and spreading infectious diseases.
Although COVID-19 paused our original plans, we were ultimately able to reach more people than we ever could have via in-person presentations alone.
Pirtobrutinib is under investigation in clinical trials in patients with CLL/small lymphocytic lymphoma, mantle cell lymphoma, and non-Hodgkin lymphoma.
In this episode of Public Health Matters, Christina Madison discusses pharmacist-physician collaborations with Amina Abubakar and Stephen Lewis.
The use of adulterated cannabinoids mixed with insecticides is becoming more common.
Because pharmacists are one of the most accessible health care providers, we are trained in medication selection and in how to counsel patients who wish to stop smoking.
The objective of this study is to evaluate the use of low-dose pioglitazone, without relying on high doses of insulin, by enhancing sensitivity as a suitable, cost-effective strategy compared to larger insulin doses in patients with limited access to care.
As staffing pressures continue straining pharmacy operations, the right automation solutions offer a path to driving growth and maintaining safety standards, all while better utilizing current personnel.
This retrospective cohort study provides preliminary evidence for safe removal of mesna from VAdriaC cycles, as the incidence of hemorrhagic cystitis did not increase in patients with Ewing sarcoma who received cyclophosphamide without prophylactic mesna.
Pharmacists, in particular, must be cautious and deliberate in using ChatGPT to ensure that its benefits are fully realized while minimizing risk and misinformation.
A centralized, artificial intelligence–driven approach can integrate diverse data and foster multidisciplinary collaboration.
Eighteen states have enacted legislation that allows pharmacists to help patients when providers are not reachable.
An overview of the use of direct oral anticoagulants as an alternative to warfarin in the treatment of left ventricular thrombus.
Study data demonstrate large step forward for this patient population
Patients often turn to dietary supplements for the management of osteoarthritis, one of which is turmeric.
Community pharmacists should consider leaning on their specialty pharmacist peers, where available, as we continue to navigate the new, more virtual normal and attempt to expand these types of services in the future.
Training and knowledge about appropriate communication with individuals of diverse backgrounds improves adherence, outcomes.
Cardioprotective antihyperglycemic agents are underutilized for inpatient care in heart failure patients. Lack of use can lead to preventable patient deaths and hospital readmissions.